Quantcast

Latest arthritis Stories

2014-06-30 08:30:15

GREENWOOD VILLAGE, Colo., June 30, 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that it has started patient enrollment for the MULTIPLE INJECTIONS STUDY using Ampion(TM) for patients with mostly severe or very severe osteoarthritis (mostly severe Kellgren-Lawrence grade 3 and 4) of the knee for which there is no current non-surgical therapy. http://photos.prnewswire.com/prnvar/20120516/MM09116LOGO Ampio's CEO, Mike Macaluso, explained, "This study is...

2014-06-30 08:30:07

Celebrating More Than 30 Years of Medical Advancements, Fighting for a Cure ATLANTA, June 30, 2014 /PRNewswire-USNewswire/ -- Children with arthritis, caregivers, doctors and researchers from across the nation will convene in Keystone, Colo., for the Arthritis Foundation National Juvenile Arthritis Conference, held July 3-6 in conjunction with Juvenile Arthritis Awareness Month. Approximately 1,000 attendees will have the opportunity to network with those who share similar...

2014-06-26 23:02:08

Patient advocacy group teams with The Dermatologist to educate healthcare providers on the specifics of psoriasis research and treatment. Malvern, PA (PRWEB) June 26, 2014 The Dermatologist, a leading publication in the field of dermatology, is proud to announce a collaboration with the National Psoriasis Foundation, the world’s leading patient advocacy organization dedicated to the 7.5 million Americans with psoriasis and psoriatic arthritis, to educate dermatologists on the latest...

2014-06-26 08:28:32

NPF Psoriatic Arthritis Project to improve diagnosis, care and treatment for millions PORTLAND, Ore., June 26, 2014 /PRNewswire-USNewswire/ -- Millions of Americans with psoriatic arthritis--a serious disease that causes pain, swelling and stiffness of the joints and tendons, and can result in joint damage if left untreated--struggle to get the health care and treatments they need to manage their condition. National Psoriasis Foundation plans to change that by launching the largest...

2014-06-19 23:14:24

As Arthritis Action Month drew to a close in May, the Arthritis Foundations and United States Center for Disease Control brought to the forefront the importance of becoming educated on arthritis and other rheumatic conditions (or AORC) and arthritis related care issues, as presented in this infographic from EntraCell. Los Angeles, CA (PRWEB) June 19, 2014 One in two adults, 65 years and older, suffer through arthritis pain. Managing pain is a harsh reality when growing older, so any...

Man With Hair-Loss Disease Gets New Growth Using Arthritis Drug
2014-06-19 15:21:48

Gerard LeBlond for redorbit.com - Your Universe Online Doctors at Yale University administered treatment for a non curable disease (alopecia universalis) in a 25-year-old man that left him without any hair. After the treatment, the man grew a full head of hair, eyebrows, eyelashes, armpit, facial and other hair on various parts of his body. His disease had not been previously treated and this was the first reported case with successful results. “The results are exactly what we...

2014-06-18 08:28:40

~Expert panel shares tips, encouraging patients to take a 360° approach to managing their disease and to not give up until they're satisfied~

2014-06-17 08:29:23

SANTA BARBARA, June 17, 2014 /PRNewswire-iReach/ -- ActiveLife (Scientific), a medtech company developing first-in-kind technology for measurement of tissue health, today announced that internationally renowned patient advocacy leader and health policy expert Amye Leong has been appointed to the Company's Board of Directors. Photo - http://photos.prnewswire.com/prnh/20140616/118357 "Amye brings unique insights into health policy, particularly from a patient's perspective. She...

2014-06-12 00:22:01

Both doses of investigational drug sarilumab met all three co-primary endpoints PARIS and TARRYTOWN, N.Y., June 12, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today presented positive results from a phase 3 trial of investigational drug sarilumab in rheumatoid arthritis (RA) patients who were inadequate responders to methotrexate (MTX) therapy. New data presented at the meeting showed that sarilumab increased major clinical...

2014-06-11 16:27:22

Phase 3 Program Underway to Further Assess Brodalumab as Potential Treatment for People Living With Psoriatic Arthritis THOUSAND OAKS, Calif. and LONDON, June 11, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and AstraZeneca today announced that results from a Phase 2 study evaluating brodalumab in 168 patients with psoriatic arthritis were published in The New England Journal of Medicine (NEJM). These data will also be presented at the 2014 European League Against Rheumatism (EULAR)...


Latest arthritis Reference Libraries

Weather Reference Library
2012-05-21 10:01:55

Can someone with arthritis forecast the weather? It is possible even though most people don’t think so. Anyone that has some form of arthritis can tell you when it’s about to get colder as there joints start to flare up and the pain starts to increase. This is because the temperature is getting colder and high pressure is moving into the area. When high pressure moves into an area it is made up of colder weather which is the cold air sinking from the upper levels of the atmosphere down...

More Articles (1 articles) »
Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.